accountand led the Biotechnology commercial, marketing, clinical, research and development teams since 2008. Dr. Paya joined Elan from Eli Lilly & Company, where he was Vice President, Lilly Research Laboratories, and Global Leader of the Diabetes and Endocrine...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Immune Design Corp. Appoints Pharma And Biotech Executive Carlos V. Paya, MD, PhD As Chief Executive Officer
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account